Related Experiment Video
Updated: Mar 28, 2026
10:07
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
15.7K
Novel KCNQ2 channel activators discovered using fluorescence-based and automated patch-clamp-based high-throughput
Jin-feng Yue1, Guan-hua Qiao1, Ni Liu2,3
1CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, State Key Laboratory of Drug Research, Chinese Academy of Sciences, Shanghai 201203, China.
Acta Pharmacologica Sinica
|January 5, 2016
Summary
Researchers developed a new high-throughput screening (HTS) method to find KCNQ2 channel activators. This efficient technique identified 38 novel KCNQ2 activators from 80,000 compounds, aiding drug discovery.
Area of Science:
- Pharmacology
- Neuroscience
- Biophysics
Background:
- KCNQ2 channels are crucial targets for neurological disorders.
- Developing efficient screening methods is essential for identifying novel KCNQ2 modulators.
Purpose of the Study:
- To establish improved, high-throughput screening (HTS) techniques for identifying novel KCNQ2 channel activators.
Main Methods:
- Stable expression of KCNQ2 channels in CHO cells.
- Primary screening using thallium flux assay.
- Hit validation with 384-well automated patch-clamp (IonWorks Barracuda).
- Characterization of validated activators using conventional patch-clamp recordings.
Main Results:
- Screening 80,000 compounds identified 565 initial hits via thallium flux assay.
- Automated patch-clamp validated 38 compounds as significant KCNQ2 activators.
- Two compounds, ZG1732 and ZG2083, showed potent KCNQ2 activation with EC50 values of 1.04±0.18 μmol/L and 1.37±0.06 μmol/L, respectively.
Conclusions:
- The combined thallium flux assay and automated patch-clamp approach provides an efficient HTS strategy.
- This HTS route effectively discovers novel KCNQ2 channel activators.
- The validated compounds represent promising leads for KCNQ2-related therapeutic development.
